Advertisement
Screener

TREVENA, INC. Patents: Applications Rejected

TREVENA, INC. Patent Applications Rejected

12 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-05-10: Application 18314913; Invention 5-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME; Applicant Trevena, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2023-04-05: Application 18296018; Invention COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME; Applicant Trevena, Inc.; Status Abandonment for Failure to Correct Drawings/Oath/NonPub Request.
  • 2022-09-30: Application 17936956; Invention Beta-Arrestin Effectors and Compositions and Methods of Use Thereof; Applicant Trevena, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-04-20: Application 17235254; Invention Beta-Arrestin Effectors and Compositions and Methods of Use Thereof; Applicant Trevena, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-05-10183149135-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAMETrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20230303531A1
Aimee Crombie Speerschneider
Dennis Shinji Yamashita
Philip Michael Pitis
Michael John Hawkins
Guodong Liu
Tamara Ann Miskowski Daubert
Catherine C.K. Yuan
Robert Borbo Kargbo
Robert Jason Herr
Donna Romero
United States
United States
United States
United States
United States
United States
United States
United States
United States
United States
LEESER, ERICH A
2023-04-0518296018COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAMETrevena, Inc.Abandonment for Failure to Correct Drawings/Oath/NonPub RequestUS20230234946A1
Philip Michael Pitis
Robert Eugene Boyd
Tamara Ann Miskowski Daubert
Michael John Hawkins
Guodong Liu
Aimee Crombie Speerschneider
United States
United States
United States
United States
United States
United States
JARRELL, NOBLE E
2022-09-3017936956Beta-Arrestin Effectors and Compositions and Methods of Use ThereofTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20240025949A1
Mark Demitrack
United States
COFFA, SERGIO
2021-04-2017235254Beta-Arrestin Effectors and Compositions and Methods of Use ThereofTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210324005A1
Mark A. Demitrack
United States
BRADLEY, CHRISTINA
2020-02-2616801567Methods of Treating HyperalgesiaTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20210023043A1
Conrad Cowan
Michael Koblish
Michael W. Lark
United States
United States
United States
BORI, IBRAHIM D
2018-06-2116064783COMBINATIONS OF OPIOID RECEPTOR LIGANDS AND CYTOCHROME P450 INHIBITORSTREVENA, INC.Abandoned -- Failure to Respond to an Office ActionUS20190008803A1
Jonathan D. VIOLIN
David G. SOERGEL
United States
United States
JAVANMARD, SAHAR
2017-02-1715436214Synthesis of Beta-Arrestin EffectorsTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20180016301A1
Nhut K. Diep
Yuriy Kalyan
Graham Lawton
Matthew Ronsheim
Shao Hong Zhou
Saibaba Racha
United States
United States
United States
United States
United States
United States
YANG, KAIPEEN E
2016-12-0515369067Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20170298094A1
Dennis Yamashita
Xiao-Tao Chen
United States
United States
COFFA, SERGIO
2016-11-0715345234Crystalline And Amorphous Forms Of A Beta-Arrestin EffectorTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20170283464A1
Ritesh Sanghvi
Gregory Alcorn
Graham Richard Lawton
Meiki Yu
Matthew Ronsheim
Jiaher Tian
Shao Hong Zhou
Yuriy B. Kalyan
United States
United States
United States
United States
United States
United States
United States
United States
HELLMAN, KRISTINA M
2015-02-2514631461Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20150166604A1
Dennis Yamashita
Xiao-Tao Chen
United States
United States
COFFA, SERGIO
2014-12-2214579956Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTrevena, Inc.Abandoned -- Failure to Respond to an Office ActionUS20150105316A1
Dennis Yamashita
Xiao-Tao Chen
United States
United States
COFFA, SERGIO
18705814METHODS OF PREPARING 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDSTrevena, Inc.Abandoned -- Incomplete Application (Pre-examination)
Paul Gauvreau
Xiaowei Yang
Shufeng Fan
United States
China
China